Plasmid vectors based on pMB8, such as pBR322, pUC 18, pGEM5 and pBluescript (1) , have become virtually indispensable tools in molecular biology. Unfortunately, pMB8 derived vectors are restricted to Entembacteriacea. Transfer of cloned DNA fragments into other bacterial species therefore necessitates alternative plasmid vectors. Insertion of the gene of interest into such (broad-host-range) plasmids may be time consuming and is often difficult to accomplish due to the lack of suitable restriction sites, expression signals and genetic markers. In this paper I report a simple procedure for the introduction of genes cloned in pBR322-type vectors into organisms which do not support the replication of these plasmids. The procedure consists of the insertion in vitro of an antibiotic resistance cassette into the plasmid of interest, followed by transposition in vivo of the relevant part of the plasmid into a shuttle vector.
I anticipated that a single copy of the transposon Tni inverted repeat would be conserved in many pBR322 type plasmids, especially those which still bear the P-lactamase and the pMB8 origin of replication on a single contiguous DNA fragment. This assumption was confirmed by inspection of the published sequences of the following non-exhaustive list of cloning vectors: pBluescript SK, pBR322, pEMBL8, pGEM5, pJRD184, pKK233.8, pKOl, pMAC5-8, pSPORT-1; pUC 18. Insertion of a second copy of the 38 bp To? inverted repeat in the proper orientation into these 'pBR322 type' vectors would fulfill the minimal in cis requirements for transposition and would thus render part of their sequences transposable in the presence of Tni transposase in vivo (2) . Such an insertion is facilitated by the antibiotic resistance cassettes shown in Table 1 . pBR322 type plasmids as source of transposable sequences Figure 1 , which encode either kanamycin or tetracycline resistance and bear a copy of the 38 bp inverted repeat at their extremities.
A typical experiment is illustrated in Figure 2 . The Escherichia coli thy A gene present in the pBR322 derivative pBTAH1.2 (3) was rendered transposable by the insertion of a 1673 bp kanamycin cassette, obtained from plasmid pGMK833 by BamHl digestion. Next, the thyA gene, flanked by the ampicillin and kanamycin resistance markers, was inserted into broad host range plasmid R751 by transposition. This was done by transforming E.coli MS967, carrying plasmids pSC259, encoding Tni transposase, and the shuttle plasmid R751 (2), with pBTAH1.2::Kml plasmid DNA. As controls, pBTAH1.2::Km2 DNA, in which the kanamycin resistance cassette had been inserted in the inverse orientation, and unmodified pBTAH1.2 were also introduced into MS967. Transposition of the thy A gene into conjugative plasmid R751 was detected by mating 10 6 MS967(pBTAH1.2::Kml) with a >10-fold excess of the E.coli MC4100 thyA mutant Exconjugants were obtained at a frequency of-0.04% per donor per generation. I have tested 300 R15i::thyA exconjugants, all of which were found to be resistant to ampicillin, kanamycin and trimethoprirn and to complement the thymidylate synthase mutation of MC4100(f/iyA), suggesting that the plasmid coded thyA fragment was copied faithfully into the shuttle vector R751. The integrity of the transposable fragments was confirmed by restriction mapping of four R15\::thyA recombinants (results not shown). No recombinants were obtained from MS967 transformed with either of the two control plasmids. 
100
"Markers encoded by the DNA fragment flanked by the two Tni inverted repeats.
•Transposition was evaluated by transforming MS967 with plasmid DNA into which a Tni cassette had been inserted, transferring R751 recombinants to a plasmid free E.coli strain, and selecting for the marker encoded by the inserted cassette (kanamycin or tetracycline resistance). The fidelity of transposition is defined as the percentage of exconjugants which bear all the transposable markers. In all cases >50 exconjugants were tested. I have tested a number of other plasmid vectors using the protocol outlined above. In all cases the predicted plasmid sequences were rendered transposable by the insertion of the kanamycin or the tetracycline cassette, and were stabily inserted into broad host range vector R751 (Table 1 ). This confirmed that in these plasmid vectors the 38 bp transposon inverted repeat downstream of the P-lactamase gene was functionally intact. In these experiments, I took advantage of conjugation of plasmid R751 to identify transposition recombinants, and to transfer the DNA fragment of choice into alternative bacterial host backgrounds. Recombinants of plasmid R751 were readily transferable from one E.coli strain to another and may be transferred to a wide variety of Gram-negative bacteria (2) . The procedure is straight forward, reliable, and quick: cassette insertion, transformation of E.coli MS967, and conjugation can be completed within 2 days.
If, alternatively, a non-conjugati ve shuttle vector would be used as a target for transposon insertion, extraction of plasmid DNA from the transposition proficient E.coli strain (carrying pSC259 and the shuttle vector of choice) followed by transformation of plasmid free E.coli, selecting the appropriate markers, may yield appreciable amounts of transposition recombinants, as the observed transposition frequencies are high (2) . Although I have focused here on the application of the system to cloning in Gram-negative bacteria, TnJ mediated gene transfer is potentially applicable to all organisms for which shuttle vectors are available. Km2. E.coli MS967 bearing plasmid pSC259 encoding TnJ transposase and conjugative plasmid R751, encoding trimethoprim resistance, was transformed with the thyA plasmids to ampicillin resistance. In this strain, pBTAH1.2::Kml can act as a substrate for TnJ transposase, whereas pBTAHl .2Km2 cannot, due to the relative orientation of the TnJ inverted repeats. Transposition events were identified by conjugation of the shuttle vector to Kcoli MC4100 (thyA).
